Intuitive Surgical, Inc. $ISRG Shares Sold by BSN CAPITAL PARTNERS Ltd

Key Points

• BSN Capital Partners cut its Intuitive Surgical stake by 41.5% in the first quarter, selling 71,000 shares and retaining 100,000 shares valued at approximately $49.6 million. Institutional investors still own 83.64% of the company.
• Intuitive Surgical beat quarterly expectations with EPS of $2.80 and revenue of $2.89 billion, representing 18.4% year-over-year revenue growth. Shares recently traded near $353, well below their 52-week high of $603.88.
• Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and an average price target of $509.02, though some firms have downgraded or lowered targets amid concerns over softer U.S. procedure growth, deferred care and the stock’s premium valuation.

BSN CAPITAL PARTNERS Ltd reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 41.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 100,000 shares of the medical equipment provider's stock after selling 71,000 shares during the quarter. Intuitive Surgical accounts for 2.2% of BSN CAPITAL PARTNERS Ltd's investment portfolio, making the stock its 8th biggest holding. BSN CAPITAL PARTNERS Ltd's holdings in Intuitive Surgical were worth $49,625,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of ISRG. Norges Bank bought a new position in Intuitive Surgical during the fourth quarter worth $2,856,987,000. J. Stern & Co. LLP increased its stake in Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider's stock valued at $1,204,788,000 after acquiring an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in Intuitive Surgical by 1,043.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider's stock valued at $760,124,000 after acquiring an additional 1,224,734 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Finally, Polen Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $477,225,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $353.33 on Monday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The company's fifty day moving average is $398.27 and its 200-day moving average is $451.13. The company has a market capitalization of $124.82 billion, a PE ratio of 40.47, a P/E/G ratio of 2.55 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to analysts' expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm's revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter last year, the company posted $1.81 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of several recent research reports. Barclays set a $651.00 price objective on Intuitive Surgical and gave the stock an "overweight" rating in a report on Thursday, April 23rd. Leerink Partners reduced their target price on Intuitive Surgical from $573.00 to $454.00 and set an "outperform" rating for the company in a research report on Friday, July 17th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a "sell" rating on the stock in a report on Tuesday, June 2nd. HSBC cut shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective for the company. in a research note on Thursday. Finally, Piper Sandler set a $357.44 price objective on shares of Intuitive Surgical in a report on Monday, July 27th. Twenty analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $509.02.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS upgraded ISRG, arguing that the recent selloff was excessive. The firm’s revised price target of $475 implies meaningful upside and may be supporting renewed investor interest. UBS upgrades Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s expansion beyond urology into general surgery and other specialties could create additional procedure growth and increase long-term demand for da Vinci systems, instruments and related services. Robotic surgery expansion beyond urology
• Positive Sentiment: Analyst sentiment remains broadly favorable, with the brokerage consensus at “Moderate Buy.” The company’s recurring revenue from instruments and accessories, expanding installed base and durable robotic-surgery demand remain key bullish arguments. Brokerage consensus on Intuitive Surgical
• Neutral Sentiment: Zacks highlighted the unusually high level of investor interest in ISRG, but the article did not provide a new earnings or guidance catalyst. Zacks investor attention report
• Neutral Sentiment: An executive’s small stock sales were made under a pre-arranged Rule 10b5-1 plan and reduced his holdings by roughly 2%, making them unlikely to materially alter the investment case. Intuitive Surgical insider sale
• Negative Sentiment: HSBC lowered Intuitive Surgical from Buy to Hold and set a $391 price target. Although that target remains above recent trading levels, the downgrade signals reduced confidence in the stock’s near-term upside. HSBC downgrades Intuitive Surgical
• Negative Sentiment: Despite a quarterly revenue and earnings beat, investors remain concerned about softer U.S. procedure growth, deferred care and the premium valuation. Those worries have contributed to continued pressure in the shares. Intuitive Surgical post-earnings selloff

Insiders Place Their Bets

In other news, SVP Iman Jeddi sold 5,625 shares of the firm's stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the transaction, the executive vice president directly owned 5,720 shares of the company's stock, valued at $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 6,634 shares of company stock valued at $2,796,795 over the last ninety days. Insiders own 0.60% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.